Position in NVO
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,144,297
+$1,532,140 QoQ
Shares Held
107,307
+9.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#217
of 1,348 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AZZAD ASSET MANAGEMENT INC /ADV holds $52,280,324 across 9 Drug Manufacturers - General names. NVO ranks #6 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
87,982 | $11,305,687 | |
| 2 | ABBV |
AbbVie Inc.
|
31,610 | $7,954,340 | |
| 3 | LLY |
ELI LILLY & Co
|
5,597 | $6,713,210 | |
| 4 | AZN |
Astrazeneca PLC
|
32,868 | $6,232,430 | |
| 5 | JNJ |
Johnson & Johnson
|
24,292 | $6,169,439 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
107,307 | $5,144,297 | |
| 7 | NVS |
Novartis AG
|
30,427 | $4,768,519 | |
| 8 | AMGN |
Amgen Inc
|
9,364 | $3,390,891 |
All Filings in NVO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,144,297 | 107,307 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,612,157 | 98,290 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,340,068 | 65,646 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,616,116 | 65,167 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $4,418,246 | 64,014 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,717,123 | 53,530 | Shares | Sole | 2025-04-16 | |
| 2024-09-30 | $4,894,610 | 41,107 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $3,764,910 | 26,376 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $4,515,571 | 35,168 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,618,163 | 34,975 | Shares | Sole | 2024-04-01 | |
| 2023-09-30 | $3,074,863 | 33,812 | Shares | Sole | 2024-04-01 | |
| 2023-06-30 | $2,755,641 | 17,028 | Shares | Sole | 2024-04-01 | |
| 2023-03-31 | $2,698,059 | 16,954 | Shares | Sole | 2024-04-01 | |
| 2022-12-31 | $2,558,061 | 18,901 | Shares | Sole | 2024-04-01 | |
| 2022-09-30 | $4,034,417 | 40,494 | Shares | Sole | 2024-04-01 | |
| 2022-06-30 | $4,862,136 | 43,634 | Shares | Sole | 2024-04-01 | |
| 2022-03-31 | $2,339,823 | 21,070 | Shares | Sole | 2024-04-01 | |
| 2021-12-31 | $2,333,296 | 20,833 | Shares | Sole | 2024-04-01 | |
| 2021-09-30 | $2,169,729 | 22,599 | Shares | Sole | 2024-04-01 | |
| 2021-06-30 | $2,334,251 | 27,865 | Shares | Sole | 2024-04-01 | |
| 2021-03-31 | $1,673,701 | 24,825 | Shares | Sole | 2024-04-01 | |
| 2020-12-31 | $1,637,912 | 23,449 | Shares | Sole | 2024-04-01 | |
| 2020-09-30 | $1,580,226 | 22,760 | Shares | Sole | 2024-04-01 | |
| 2020-06-30 | $1,426,743 | 21,789 | Shares | Sole | 2024-04-01 | |
| 2020-03-31 | $1,542,625 | 25,625 | Shares | Sole | 2024-04-01 | |
| No filing history on record for this holder in this stock. | ||||||